ANTI-RHEUMATIC NONSTEROID DRUGS IN THERAPY OF PATIENTS WITH RHEUMATOID-ARTHRITIS

被引：0
|
作者：
DORMIDONTOV, EN
KORSHUNOV, NI
BARANOVA, EY
机构：
来源：
TERAPEVTICHESKII ARKHIV | 1978年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10 / 13
页数：4
相关论文
共 50 条
  • [31] Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
    Xerxes Pundole
    Natalia V. Zamora
    Harish Siddhanamatha
    Heather Lin
    Jean Tayar
    Leung Cheuk Hong
    Liang Li
    Maria E. Suarez-Almazor
    [J]. Clinical Rheumatology, 2020, 39 : 787 - 794
  • [32] Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
    Pundole, Xerxes
    Zamora, Natalia V.
    Siddhanamatha, Harish
    Lin, Heather
    Tayar, Jean
    Hong, Leung Cheuk
    Li, Liang
    Suarez-Almazor, Maria E.
    [J]. CLINICAL RHEUMATOLOGY, 2020, 39 (03) : 787 - 794
  • [33] Use of disease-modifying anti-rheumatic drugs and cardiovascular events in patients with rheumatoid arthritis
    Kaminski, Matthew
    Shishehbor, Mehdi H.
    Gutierrez, Antonio
    Amini, Mohammad R.
    Coats, Walter
    Moghbelli, Meisam
    Askari, Arman T.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A370 - A370
  • [34] DRUG-CONTROL OF AN ANTI-RHEUMATIC IN RHEUMATOID-ARTHRITIS VIA SCINTIGRAPHY OF JOINTS
    KAFARNIK, D
    SEMMLER, U
    WIEGMANN, A
    PFANNENSTIEL, P
    [J]. AKTUELLE RHEUMATOLOGIE, 1979, 4 (03) : 133 - 137
  • [35] Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis
    Giachi, Andrea
    Cugno, Massimo
    Gualtierotti, Roberta
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [36] THE IMPACT OF EDUCATION ON ADHERENCE TO TREATMENT WITH DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS PATIENTS
    Holc, I.
    Pahor, A.
    Gradisnik, S.
    Dai, K.
    Krajnc, M. Koren
    Grobelsek, V. Kovacic
    Dobnik, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 706 - 707
  • [37] Persistence on Disease Modifying Anti-Rheumatic Drugs Among Taiwan Established Rheumatoid Arthritis Patients
    Liu, Yi-Han
    Lin, Tzu-Chieh
    Yang, Yea-Huei Kao
    Chang, Hui-Jen
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 73 - 73
  • [38] Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs)
    vanGestel, AM
    Haagsma, CJ
    Furst, DE
    vanRiel, PLCM
    [J]. BAILLIERES CLINICAL RHEUMATOLOGY, 1997, 11 (01): : 65 - 82
  • [39] SECONDARY SARCOPENIA IN RHEUMATOID ARTHRITIS PATIENTS TREATED BY BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Hasegawa, Eriko
    Ito, Satoshi
    Kurosawa, Yoichi
    Kobayashi, Daisuke
    Abe, Asami
    Otani, Hiroshi
    Nakazono, Kiyoshi
    Murasawa, Akira
    Narita, Ichiei
    Ishikawa, Hajime
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1622 - 1622
  • [40] Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review
    Giollo, Alessandro
    Bissell, Lesley-Anne
    Buch, Maya H.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2018, 17 (07) : 697 - 708
12345